IQE Lifts 2026 Outlook Past 40% Revenue Growth on AI Optical Sales
IQE raised its 2026 outlook to revenue growth above 40% after AI optical opportunities converted into revenue. First-half sales rose 43% to £64.6 million.
By Daniel Okafor
3 min read

What's News
- IQE forecasts full-year 2026 revenue growth above 40%, raised from 30% on November 17, 2026.
- First-half 2026 revenue rose 43% to £64.6 million, with adjusted EBITDA of £6.0 million.
- Photonics revenue grew 45% to £38.5 million in the first half.
- Net cash from operations fell to £1.2 million from £3.6 million a year earlier.
- IQE held £41.5 million in cash and has 2027 order-book coverage in place.
IQE now forecasts full-year 2026 revenue growth above 40%, up from its previous guidance of more than 30%, after AI and data-centre optical-communications opportunities converted into revenue. The compound semiconductor wafer supplier announced the raised outlook in a trading update on November 17, 2026. It also expects adjusted EBITDA in the mid-teens of millions of pounds, an increase from the low-teens guidance issued in July.
Chief executive Jutta Meier said disciplined operational execution supported the upgrade. She added that strong order-book coverage was already in place for 2027, giving the company order visibility into the following year. IQE held £41.5 million in current cash and remained free of bank debt.
What changed between July and November?
The July 21, 2026 trading update had set guidance at revenue growth above 30% and adjusted EBITDA in the low teens of millions of pounds. That upgrade followed first-half trading which exceeded management expectations. Demand for indium phosphide (InP), the material used in optical photonics products for data centres and AI infrastructure, was accelerating at the time.
Three months earlier, the numbers were already strong. The September 7, 2026 interim results reported first-half revenue up 43% to £64.6 million. Adjusted EBITDA reached £6.0 million, against a loss of £0.4 million a year earlier.
Photonics revenue rose 45% to £38.5 million in the first half. IQE credited US military and defence programme funding releases plus growth in AI and data-centre-related markets. The company attributed first-half gross-margin expansion to higher manufacturing-asset utilisation and a product mix weighted toward photonics sales.
One caveat matters here. Photonics also serves defence programmes, so the segment's growth is not a standalone measure of AI demand. The two revenue streams share the same wafer platform.
Why did cash lag behind earnings?
Reported net cash from operations declined to £1.2 million in the first half, down from £3.6 million a year earlier. Higher revenue and adjusted EBITDA were partly offset by a £4.0 million working-capital outflow and £2.4 million of restructuring and strategic-review costs. In short, the profit line improved faster than the cash line.
The gap is a working-capital story. Growth forced cash into inventory and receivables before it returned as collections, and restructuring costs took another bite out of operating cash flow even as adjusted earnings improved.
How is IQE building capacity for AI demand?
The September interim results set out a second-half 2026 conversion of existing tooling to increase InP capacity for significant AI and data-centre demand. The results also flagged potential optical-communications upside underpinned by recently signed supply agreements. Those are the opportunities now reported as converted into revenue.
The technology work extends beyond InP. IQE reported qualifications in:
- gallium-arsenide-based optical interconnect technologies;
- gallium-nitride-on-silicon power epitaxy for high-efficiency AI and data-centre power supply units.
The company is also developing and sampling gallium-nitride-on-silicon microLED epitaxy with partners serving hyperscalers, targeting high-bandwidth, energy-efficient data transfer in AI data centres.
What is the test ahead?
The guidance sequence shows AI optical work moving from identified opportunity to recognised revenue, with supply agreements supporting the commercial ramp. The next execution test is whether the planned InP capacity increase and the 2027 order coverage can sustain that growth while cash generation catches up with adjusted earnings.
Source: unite.ai
More from Daniel Okafor
Show full bio
Correspondent covering money, funding and market shifts around entrepreneurship, startups and venture funding at Business Bearings.
2,206 articles